BeStock  
Stocks › Biotechnology › ABCL

AbCellera Biologics ABCL

US equityMarket cap rank #2395BiotechnologyAI medical concept stocks
$9.69 −$0.78 (-7.45%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.73 +0.41%
Open$10.14
Prev close$10.47
Day range$9.58 – $10.26
Volume4.25M
Market cap$3.16B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$10.64M+18.8% YoY
Operating profit-$49.68M+32.5% YoY
Net profit-$40.76M+28.6% YoY
Diluted EPS-$0.13+31.6% YoY
Free cash flow$25.30M+141.1% YoY
Operating cash flow$26.91M

Revenue, last 8 quarters

$5.1MDec '24$4.2MMar '25$17.1MJun '25$9.0MSep '25$44.9MDec '25$8.3MMar '26$4.1MJun '26$10.6MSep '26

Net profit, last 8 quarters

$-34.2MDec '24$-45.6MMar '25$-34.7MJun '25$-57.1MSep '25$-8.9MDec '25$-43.2MMar '26$-55.4MJun '26$-40.8MSep '26

Diluted EPS by quarter

-0.11Dec '24-0.15Mar '25-0.12Jun '25-0.19Sep '25-0.03Dec '25-0.14Mar '26-0.18Jun '26-0.13Sep '26

Free cash flow by quarter

$-23.6MDec '24$-22.2MMar '25$-45.8MJun '25$-61.5MSep '25$-44.6MDec '25$-37.4MMar '26$23.8MJun '26$25.3MSep '26

Annual revenue

$233.2MFY20$375.2MFY21$485.4MFY22$38.0MFY23$28.8MFY24$75.1MFY25

Profitability & balance sheet

Operating margin-275.7%
Net margin-218.6%
Return on equity-14.6%
Return on assets-10.4%
Return on invested capital-14.3%
Current ratio12.43
Liabilities / assets29.2%
Cash & investments$764.42M
Total debt$128.13M
Net cash (debt)$636.29M

Where the revenue comes from

Quarter 2025/FY

By region

  • Canada$64.00M 85.2%
  • United States$11.10M 14.8%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $10.64M $4.05M $8.32M $75.13M $44.85M
Total Operating Revenue $10.64M $4.05M $8.32M $75.13M $44.85M
Operating Expense $60.32M $62.97M $61.50M $278.34M $70.12M
Selling and Admin Expenses $13.61M $13.85M $12.33M $83.23M $17.22M
Research & Development $43.54M $45.99M $46.66M $186.83M $50.09M
Depreciation & Amortization & Depletion $6.81M $6.99M $6.84M $22.17M $6.12M
-Depreciation & Amortization $6.81M $6.99M $6.84M $22.17M $6.12M
Other Operating Expenses -$3.64M -$3.85M -$4.34M -$13.89M -$3.32M
Operating Profit -$49.68M -$58.92M -$53.18M -$203.21M -$25.27M
Net Non-Operating Interest Income (Expense) $6.87M -$42,000.00 $3.64M $28.33M $8.48M
Non-Operating Interest Income $6.87M – $3.64M $28.33M $8.48M
Pretax Profit -$42.81M -$58.97M -$49.54M -$177.60M -$19.50M
Tax -$2.05M -$3.54M -$6.37M -$31.18M -$10.55M
Net Profit -$40.76M -$55.43M -$43.17M -$146.41M -$8.95M
Profit from Continuing Operations -$40.76M -$55.43M -$43.17M -$146.41M -$8.95M
Net Income to Parent Company -$40.76M -$55.43M -$43.17M -$146.41M -$8.95M
Net Income to Common Stockholders -$40.76M -$55.43M -$43.17M -$146.41M -$8.95M
Basic EPS -$0.13 -$0.18 -$0.14 -$0.49 -$0.03
Diluted EPS -$0.13 -$0.18 -$0.14 -$0.49 -$0.03
Non-Operating Interest Expense – $42,000.00 – – –
Other Income (Expense) – – – -$2.71M -$153,000.00
Other Non-Operating Income (Expenses) – – – -$2.71M -$153,000.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.50B $1.31B $1.31B $1.36B $1.36B
Total Current Assets $876.16M $679.23M $664.60M $728.23M $728.23M
Cash and Cash Equivalents & Short-Term Investments $764.42M $540.10M $504.73M $533.83M $533.83M
-Cash and Cash Equivalents $163.80M $120.07M $77.06M $128.51M $128.51M
-Short Term Investments $600.62M $420.04M $427.67M $405.31M $405.31M
Receivables $67.28M $95.43M $115.73M $153.40M $153.40M
-Accounts Receivable $17.96M $18.60M $36.76M $58.29M $58.29M
-Loans Receivable $38.29M $38.42M $39.16M $39.41M $39.41M
-Taxes Receivable $11.02M $38.41M $39.80M $55.70M $55.70M
Inventory $7.57M $7.58M $7.86M $6.34M $6.34M
Restricted Cash $25.00M $25.00M $25.00M $25.00M $25.00M
Other Current Assets $11.89M $11.12M $11.28M $9.67M $9.67M
Total Non-Current Assets $623.71M $628.35M $642.52M $628.72M $628.72M
Net PPE $410.05M $416.68M $422.81M $428.00M $428.00M
-Gross PPE $485.36M $486.21M $486.34M $485.62M $485.62M
-Accumulated Depreciation -$75.31M -$69.54M -$63.53M -$57.61M -$57.61M
Investments and Advances $63.85M $65.23M $65.31M $62.58M $62.58M
-Long Term Equity Investment $63.85M $65.23M $65.31M $62.58M $62.58M
Goodwill and Other Intangible Assets $86.20M $84.34M $85.27M $86.19M $86.19M
-Goodwill $47.81M $47.81M $47.81M $47.81M $47.81M
-Other Intangible Assets $38.39M $36.53M $37.46M $38.38M $38.38M
Other Non-Current Assets $63.62M $62.10M $69.14M $51.95M $51.95M
Total Liabilities $437.36M $411.56M $369.03M $390.05M $390.05M
Total Current Liabilities $70.47M $53.19M $47.29M $64.31M $64.31M
Payables $13.73M $12.11M $20.81M $25.23M $25.23M
-Accounts Payable $13.73M $12.11M $20.81M $25.23M $25.23M
Current Accrued Expenses $7.80M $6.08M $3.93M $10.76M $10.76M
Short-Term Debt and Capital Lease Obligation $5.69M $5.67M $5.87M $5.82M $5.82M
-Current Capital Lease Obligation $5.69M $5.67M $5.87M $5.82M $5.82M
Current Deferred Liabilities $43.25M $29.34M $16.69M $22.51M $22.51M
Total Non-Current Liabilities $366.89M $358.37M $321.74M $325.74M $325.74M
Long Term Debt and Capital Lease Obligation $128.13M $129.95M $134.31M $137.40M $137.40M
-Long Term Capital Lease Obligation $128.13M $129.95M $134.31M $137.40M $137.40M
Non-Current Deferred Liabilities $228.33M $218.70M $176.11M $183.57M $183.57M
Other Non-Current Liabilities $10.44M $9.71M $11.32M $4.77M $4.77M
Total Equity $1.06B $896.02M $938.08M $966.90M $966.90M
Stockholders' Equity $1.06B $896.02M $938.08M $966.90M $966.90M
Capital Stock $996.19M $821.24M $816.53M $802.34M $802.34M
-Common Stock $996.19M $821.24M $816.53M $802.34M $802.34M
Additional Paid-In Capital $238.57M $206.00M $196.62M $198.28M $198.28M
Retained Earnings -$168.83M -$128.07M -$72.65M -$29.48M -$29.48M
Gains/Losses Not Affecting Retained Earnings -$3.42M -$3.15M -$2.42M -$4.23M -$4.23M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $26.91M $25.92M -$33.52M -$131.30M -$34.74M
Net cash flow from continuing operations $26.91M $25.92M -$33.52M -$131.30M -$34.74M
Net Income from Continuing Operations -$40.76M -$55.43M -$43.17M -$146.41M -$8.95M
Depreciation & Depletion & Amortization $8.62M $8.78M $8.66M $28.82M $7.92M
Other Non-Cash Items -$1.42M $4.64M $2.38M $1.20M -$403,000.00
Change in Working Capital $48.81M $55.64M -$13.40M -$70.69M -$46.22M
-Change in Receivables $23.20M $4.24M $13.10M -$55.62M -$19.87M
-Change in Payables and Accrued Expense $3.31M -$2.25M -$14.38M $3.46M $5.74M
-Change in Other Current Assets $2.62M $3.58M -$1.74M $17.15M $3.07M
-Change In Other Working Capital $19.67M $50.07M -$10.39M -$35.68M -$35.16M
Net cash flow from investing -$183.44M $11.34M -$25.08M $87.75M $75.14M
Net Cash Flow from Continuing Investing Activities -$183.44M $11.34M -$25.08M $87.75M $75.14M
Net PPE Purchase and Sale -$1.61M -$2.13M -$3.83M -$42.77M -$9.84M
Net Investment Purchase and Sale -$182.05M $7.88M -$22.61M $52.94M $14.76M
Net Other Investing Changes $229,000.00 $5.59M $1.36M $54.61M $47.25M
Financing Cash Flow $200.64M $6.39M $7.19M $14.08M $4.12M
Net Cash Flow from Continuing Financing Activities $200.64M $6.39M $7.19M $14.08M $4.12M
Net Other Financing Charges $11.81M $6.39M $7.19M $14.08M $4.12M
Ending Cash Balance $190.76M $147.03M $103.80M $155.25M $155.25M
Net Change in Cash $44.11M $43.66M -$51.41M -$29.46M $44.51M
Beginning Cash Balance $147.03M $103.80M $155.25M $183.62M $110.45M
Effect of Exchange Rate Changes -$379,000.00 -$430,000.00 -$38,000.00 $1.10M $290,000.00
Free Cash Flow $25.30M $23.79M -$37.35M -$174.07M -$44.59M
Net Business Purchase and Sale – – – -$7.14M -$251,000.00

Discussion

No comments yet — be the first to weigh in on ABCL.

Sign in to join the discussion.

Scroll to Top